Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2383]

Managing the side effects of CAR T-cell therapy

Misty Lamprecht - The Ohio State University James Cancer Hospital, Ohio, USA

Managing the side effects of CAR T-cell therapy ( Misty Lamprecht - The Ohio State University James Cancer Hospital, Ohio, USA )

Updates in surgical oncology

Lisa Parks - The Ohio State University James Cancer Hospital, Columbus, USA

Updates in surgical oncology ( Lisa Parks - The Ohio State University James Cancer Hospital, Columbus, USA )

Evidence-based radiation side effect management

John Hillson - Duke Cancer Institute, Durham, USA

Evidence-based radiation side effect management ( John Hillson - Duke Cancer Institute, Durham, USA )

Clinical photography in cancer care

John Hillson - Duke Cancer Institute, Durham, USA

Clinical photography in cancer care ( John Hillson - Duke Cancer Institute, Durham, USA )

Current treatment for brain tumours

Prof Mark Beresford - Royal United Hospital Bath, Bath, UK

Current treatment for brain tumours ( Prof Mark Beresford - Royal United Hospital Bath, Bath, UK )

The Brain Tumour Charity

Ms Erica Moyes - The Brain Tumour Charity, Farnborough, UK

The Brain Tumour Charity ( Ms Erica Moyes - The Brain Tumour Charity, Farnborough, UK )

Talimogene laherparepvec combined with neoadjuvant chemotherapy for non...

Dr Hatem Soliman - Moffitt Cancer Centre, Tampa, USA

Talimogene laherparepvec combined with neoadjuvant chemotherapy for non-metastatic triple negative breast cancer ( Dr Hatem Soliman - Moffitt Cancer Centre, Tampa, USA )

TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET...

Prof Lecia Sequist - Massachusetts General Hospital, Boston, USA

TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET-amplified NSCLC after progression on EGFR-TKI ( Prof Lecia Sequist - Massachusetts General Hospital, Boston, USA )

Using T cell engineering plus triple checkpoint blockade to enhance the...

Dr Kristin Anderson - Fred Hutchinson Cancer Research Center, Seattle, USA

Using T cell engineering plus triple checkpoint blockade to enhance the efficacy of adoptive immunotherapy in ovarian cancer ( Dr Kristin Anderson - Fred Hutchinson Cancer Research Center, Seattle, USA )

The hereditary link between African-Americans and people in Africa and its...

Prof John Carpten - Keck School of Medicine, Los Angeles, USA

The hereditary link between African-Americans and people in Africa and its relationship to cancer incidence and outcomes ( Prof John Carpten - Keck School of Medicine, Los Angeles, USA )

Combining the SLP vaccine with chemo-immunotherapy in order to increase the HPV...

Prof Kees Melief - Leiden University Medical Center, Leiden, Netherlands

Combining the SLP vaccine with chemo-immunotherapy in order to increase the HPV-specific T-cell response in cervical cancer ( Prof Kees Melief - Leiden University Medical Center, Leiden, Netherlands )

Digitising clinical assessment and using it for evidence-based prediction of...

Prof Jorge Nieva - Keck School of Medicine, Los Angeles, USA

Digitising clinical assessment and using it for evidence-based prediction of outcomes ( Prof Jorge Nieva - Keck School of Medicine, Los Angeles, USA )

More from ecancer